Synektik

Synektik Debt Growth

The Year-over-Year Debt Growth of Synektik (SNT.WA) as of Oct 31, 2026 is 64.25 %. In the previous year, Year-over-Year Debt Growth was 30.82 % — a change of 108.51% (higher).

Debt Growth

64.25 %

YoY

108.51%

Last updated:

Year-over-Year Debt Growth of Synektik is 2025 64.25 % . Year-over-Year Debt Growth of Synektik was 2024 30.82 % . It decreases by 108.51% higher compared to the previous year.

The Synektik Debt Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt Growth
Date
Debt Growth
Jan 1, 2018
393.83 PLN
Jan 1, 2019
-24.73 PLN
Jan 1, 2020
69.06 PLN
Jan 1, 2021
-11.71 PLN
Jan 1, 2022
103.00 PLN
Jan 1, 2023
-49.24 PLN
Jan 1, 2024
30.82 PLN
Jan 1, 2025
64.25 PLN
The Synektik Debt Growth history
YEARDebt GrowthYoY
64.25 %+108.51%
30.82 %-162.58%
-49.24 %-147.80%
103.00 %-979.89%
-11.71 %-116.95%
69.06 %-379.27%
-24.73 %-106.28%
393.83 %-1,021.75%
-42.73 %+30.65%
-32.70 %+4.98%
-31.15 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Synektik Stock analysis

What does Synektik do? Synektik SA generates revenue through its PACS software, which enables diagnostic imaging laboratories to operate efficiently. The company also sells medical equipment and provides services through its imaging equipment services center. Synektik SA partners with Siemens and holds a 100% stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o, which it acquired by raising its stake on November 28, 2013. The firm's research laboratory conducts acceptance and specialist tests on X-ray equipment, contributing to its service offerings. The primary buyers of Synektik SA's products include diagnostic imaging laboratories that require PACS software for their operations. Medical equipment is sold to healthcare facilities, while the research laboratory services are utilized by entities needing X-ray equipment testing. The company's partnership with Siemens supports its medical equipment sales and services. Synektik SA's revenue streams are derived from software licensing, medical equipment sales, and specialized testing services. The company's focus on diagnostic imaging solutions and its ownership of Miedzynarodowe Centra Medyczne Inwestycje Sp z o o position it within the medical technology sector, targeting healthcare providers and imaging laboratories. Synektik is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synektik stock

Year-over-Year Debt Growth of Synektik is 64.25 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Debt Growth Synektik since 2006 – with annual values, charts, and detailed analysis.

Debt growth measures the percentage change in total debt. Rising debt growth should be compared with revenue and earnings growth to assess sustainability.

To evaluate Year-over-Year Debt Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Debt Growth.

Year-over-Year Debt Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Debt Growth's Synektik historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Synektik

All Key Metrics — Synektik